These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18411945)

  • 21. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of antibody response to an epitope in the haemagglutinin subunit 2 of avian influenza virus H5N1 for differentiation of infected and vaccinated chickens.
    Putri K; Wibowo MH; Tarigan S; Wawegama N; Ignjatovic J; Noormohammadi AH
    Avian Pathol; 2020 Apr; 49(2):161-170. PubMed ID: 31738584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of vaccination in avian influenza control and eradication.
    Marangon S; Cecchinato M; Capua I
    Zoonoses Public Health; 2008; 55(1):65-72. PubMed ID: 18201329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza.
    Capua I; Terregino C; Cattoli G; Mutinelli F; Rodriguez JF
    Avian Pathol; 2003 Feb; 32(1):47-55. PubMed ID: 12745380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.
    Tarigan S; Indriani R; Durr PA; Ignjatovic J
    Avian Pathol; 2015; 44(4):259-68. PubMed ID: 25915110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of avian influenza infections in poultry with emphasis on vaccination.
    Capua I; Marangon S
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):751-7. PubMed ID: 17140352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Worrall EE; Sudarisman ; Priadi A
    Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences in control of avian influenza in Europe, the Russian Federation and the Middle East.
    Brown IH; Pittman M; Irza V; Laddomada A
    Dev Biol (Basel); 2007; 130():33-8. PubMed ID: 18411933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control versus no control: options for avian influenza H5N1 in Nigeria.
    Fasina FO; Meseko AC; Joannis TM; Shittu AI; Ularamu HG; Egbuji NA; Sulaiman LK; Onyekonwu NO
    Zoonoses Public Health; 2007; 54(5):173-6. PubMed ID: 17542958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccines and vaccination strategies in birds.
    van den Berg T; Lambrecht B; Marché S; Steensels M; Van Borm S; Bublot M
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):121-65. PubMed ID: 17889937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and constraints to vaccination in developing countries.
    Alders RG; Bagnol B; Young MP; Ahlers C; Brum E; Rushton J
    Dev Biol (Basel); 2007; 130():73-82. PubMed ID: 18411937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.
    Kwon JS; Kim MC; Jeong OM; Kang HM; Song CS; Kwon JH; Lee YJ
    Vaccine; 2009 May; 27(24):3189-94. PubMed ID: 19446190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens.
    Poetri ON; Bouma A; Murtini S; Claassen I; Koch G; Soejoedono RD; Stegeman JA; van Boven M
    Vaccine; 2009 May; 27(21):2864-9. PubMed ID: 19428896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus.
    Capua I; Terregino C; Cattoli G; Toffan A
    Avian Pathol; 2004 Apr; 33(2):158-63. PubMed ID: 15276982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International standards and guidelines for vaccination of poultry against highly pathogenic avian influenza.
    Bruschke C; Brückner G; Vallat B
    Dev Biol (Basel); 2007; 130():23-30. PubMed ID: 18411932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys.
    Wang L; Qin Z; Pantin-Jackwood M; Faulkner O; Suarez DL; Garcia M; Lupiani B; Reddy SM; Saif YM; Lee CW
    Vaccine; 2011 Oct; 29(45):7966-74. PubMed ID: 21907751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A geographical spread of vaccine-resistance in avian influenza epidemics.
    Iwami S; Takeuchi Y; Liu X; Nakaoka S
    J Theor Biol; 2009 Jul; 259(2):219-28. PubMed ID: 19361532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination reduced the incidence of outbreaks of low pathogenicity avian influenza in northern Italy.
    Busani L; Toson M; Stegeman A; Pozza MD; Comin A; Mulatti P; Cecchinato M; Marangon S
    Vaccine; 2009 Jun; 27(27):3655-61. PubMed ID: 19464547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "DIVA" vaccination strategy for avian influenza infections in poultry.
    Cattoli G; Milani A; Bettini F; Serena Beato M; Mancin M; Terregino C; Capua I
    Avian Pathol; 2006 Apr; 35(2):154-9. PubMed ID: 16595309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test.
    Avellaneda G; Sylte MJ; Lee CW; Suarez DL
    Avian Dis; 2010 Mar; 54(1 Suppl):272-7. PubMed ID: 20521644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.